• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

深入了解HIV-1蛋白酶 - BEA369复合物中质子化状态的功能作用:分子动力学模拟和自由能计算。

Insights into the functional role of protonation states in the HIV-1 protease-BEA369 complex: molecular dynamics simulations and free energy calculations.

作者信息

Chen Jianzhong, Yang Maoyou, Hu Guodong, Shi Shuhua, Yi Changhong, Zhang Qinggang

机构信息

Shandong Normal University, Jinan, China.

出版信息

J Mol Model. 2009 Oct;15(10):1245-52. doi: 10.1007/s00894-009-0452-y. Epub 2009 Mar 18.

DOI:10.1007/s00894-009-0452-y
PMID:19294437
Abstract

The molecular mechanics Poisson-Boltzmann surface area (MM-PBSA) method combined with molecular dynamics (MD) simulations were used to investigate the functional role of protonation in human immunodeficiency virus type 1 (HIV-1) protease complexed with the inhibitor BEA369. Our results demonstrate that protonation of two aspartic acids (Asp25/Asp25') has a strong influence on the dynamics behavior of the complex, the binding free energy of BEA369, and inhibitor-residue interactions. Relative binding free energies calculated using the MM-PBSA method show that protonation of Asp25 results in the strongest binding of BEA369 to HIV-1 protease. Inhibitor-residue interactions computed by the theory of free energy decomposition also indicate that protonation of Asp25 has the most favorable effect on binding of BEA369. In addition, hydrogen-bond analysis based on the trajectories of the MD simulations shows that protonation of Asp25 strongly influences the water-mediated link of a conserved water molecule, Wat301. We expect that the results of this study will contribute significantly to binding calculations for BEA369, and to the design of high affinity inhibitors.

摘要

结合分子动力学(MD)模拟的分子力学泊松-玻尔兹曼表面积(MM-PBSA)方法,被用于研究质子化在与抑制剂BEA369复合的1型人类免疫缺陷病毒(HIV-1)蛋白酶中的功能作用。我们的结果表明,两个天冬氨酸(Asp25/Asp25')的质子化对复合物的动力学行为、BEA369的结合自由能以及抑制剂-残基相互作用有强烈影响。使用MM-PBSA方法计算的相对结合自由能表明,Asp25的质子化导致BEA369与HIV-1蛋白酶的结合最强。通过自由能分解理论计算的抑制剂-残基相互作用也表明,Asp25的质子化对BEA369的结合具有最有利的影响。此外,基于MD模拟轨迹的氢键分析表明,Asp25的质子化强烈影响保守水分子Wat301的水介导连接。我们期望这项研究的结果将对BEA369的结合计算以及高亲和力抑制剂的设计做出重大贡献。

相似文献

1
Insights into the functional role of protonation states in the HIV-1 protease-BEA369 complex: molecular dynamics simulations and free energy calculations.深入了解HIV-1蛋白酶 - BEA369复合物中质子化状态的功能作用:分子动力学模拟和自由能计算。
J Mol Model. 2009 Oct;15(10):1245-52. doi: 10.1007/s00894-009-0452-y. Epub 2009 Mar 18.
2
Insights into effect of the Asp25/Asp25' protonation states on binding of inhibitors Amprenavir and MKP97 to HIV-1 protease using molecular dynamics simulations and MM-GBSA calculations.利用分子动力学模拟和MM - GBSA计算深入了解Asp25/Asp25'质子化状态对抑制剂安普那韦和MKP97与HIV - 1蛋白酶结合的影响。
SAR QSAR Environ Res. 2021 Aug;32(8):615-641. doi: 10.1080/1062936X.2021.1939149. Epub 2021 Jun 23.
3
Structural analysis of lead fullerene-based inhibitor bound to human immunodeficiency virus type 1 protease in solution from molecular dynamics simulations.基于分子动力学模拟对溶液中与1型人类免疫缺陷病毒蛋白酶结合的铅富勒烯基抑制剂进行结构分析。
J Mol Graph Model. 2007 Sep;26(2):558-70. doi: 10.1016/j.jmgm.2007.03.013. Epub 2007 Apr 4.
4
Structural and dynamical properties of different protonated states of mutant HIV-1 protease complexed with the saquinavir inhibitor studied by molecular dynamics simulations.通过分子动力学模拟研究与沙奎那韦抑制剂复合的突变型HIV-1蛋白酶不同质子化状态的结构和动力学性质。
J Mol Graph Model. 2006 Nov;25(3):324-32. doi: 10.1016/j.jmgm.2006.01.004. Epub 2006 Feb 28.
5
Unraveling HIV protease flaps dynamics by Constant pH Molecular Dynamics simulations.通过恒定pH分子动力学模拟解析HIV蛋白酶的瓣片动力学
J Struct Biol. 2016 Aug;195(2):216-226. doi: 10.1016/j.jsb.2016.06.006. Epub 2016 Jun 10.
6
Structure, dynamics and solvation of HIV-1 protease/saquinavir complex in aqueous solution and their contributions to drug resistance: molecular dynamic simulations.HIV-1蛋白酶/沙奎那韦复合物在水溶液中的结构、动力学和溶剂化作用及其对耐药性的影响:分子动力学模拟
J Chem Inf Model. 2005 Mar-Apr;45(2):300-8. doi: 10.1021/ci049784g.
7
Relative binding free energies of peptide inhibitors of HIV-1 protease: the influence of the active site protonation state.HIV-1蛋白酶肽抑制剂的相对结合自由能:活性部位质子化状态的影响
J Med Chem. 1995 Jan 6;38(1):42-8. doi: 10.1021/jm00001a009.
8
Exploring the drug resistance mechanism of active site, non-active site mutations and their cooperative effects in CRF01_AE HIV-1 protease: molecular dynamics simulations and free energy calculations.探讨 CRF01_AE HIV-1 蛋白酶活性位点、非活性位点突变及其协同作用的耐药机制:分子动力学模拟和自由能计算。
J Biomol Struct Dyn. 2019 Jul;37(10):2608-2626. doi: 10.1080/07391102.2018.1492459. Epub 2019 Jan 10.
9
Energetic basis for drug resistance of HIV-1 protease mutants against amprenavir.HIV-1 蛋白酶突变体对安普那韦耐药的能量基础。
J Comput Aided Mol Des. 2012 Feb;26(2):215-32. doi: 10.1007/s10822-012-9550-5. Epub 2012 Feb 14.
10
Binding free energy contributions of interfacial waters in HIV-1 protease/inhibitor complexes.HIV-1蛋白酶/抑制剂复合物中界面水的结合自由能贡献
J Am Chem Soc. 2006 Sep 13;128(36):11830-9. doi: 10.1021/ja058042g.

引用本文的文献

1
Pathway Specific Unbinding Free Energy Profiles of Ritonavir Dissociation from HIV-1 Protease.利托那韦从HIV-1蛋白酶解离的特定途径的解离自由能分布
Biochemistry. 2025 Feb 18;64(4):940-952. doi: 10.1021/acs.biochem.4c00560. Epub 2025 Feb 9.
2
Multiple Molecular Dynamics Simulations and Energy Analysis Unravel the Dynamic Properties and Binding Mechanism of Mutants HIV-1 Protease with DRV and CA-p2.多分子动力学模拟和能量分析揭示了 HIV-1 蛋白酶突变体与 DRV 和 CA-p2 的动态特性和结合机制。
Microbiol Spectr. 2022 Apr 27;10(2):e0074821. doi: 10.1128/spectrum.00748-21. Epub 2022 Mar 23.
3
Ritonavir and xk263 Binding-Unbinding with HIV-1 Protease: Pathways, Energy and Comparison.

本文引用的文献

1
Computational alanine scanning and free energy decomposition for E. coli type I signal peptidase with lipopeptide inhibitor complex.大肠杆菌I型信号肽酶与脂肽抑制剂复合物的计算丙氨酸扫描和自由能分解
J Mol Graph Model. 2008 Jan;26(5):813-23. doi: 10.1016/j.jmgm.2007.04.007. Epub 2007 May 3.
2
Molecular dynamics and free energy studies on the wild-type and double mutant HIV-1 protease complexed with amprenavir and two amprenavir-related inhibitors: mechanism for binding and drug resistance.野生型和双突变型HIV-1蛋白酶与安普那韦及两种安普那韦相关抑制剂复合的分子动力学和自由能研究:结合及耐药机制
J Med Chem. 2007 Mar 22;50(6):1177-88. doi: 10.1021/jm0609162. Epub 2007 Feb 15.
3
利托那韦与xk263和HIV-1蛋白酶的结合-解离:途径、能量及比较
Life (Basel). 2022 Jan 13;12(1):116. doi: 10.3390/life12010116.
4
Determination of the protonation state of the Asp dyad: conventional molecular dynamics versus thermodynamic integration.天冬氨酸二元组质子化状态的测定:传统分子动力学与热力学积分法
J Mol Model. 2016 Mar;22(3):58. doi: 10.1007/s00894-016-2926-z. Epub 2016 Feb 17.
5
Probing Difference in Binding Modes of Inhibitors to MDMX by Molecular Dynamics Simulations and Different Free Energy Methods.通过分子动力学模拟和不同的自由能方法探究抑制剂与MDMX结合模式的差异。
PLoS One. 2015 Oct 29;10(10):e0141409. doi: 10.1371/journal.pone.0141409. eCollection 2015.
6
Conformational variation of an extreme drug resistant mutant of HIV protease.HIV蛋白酶极端耐药突变体的构象变异
J Mol Graph Model. 2015 Nov;62:87-96. doi: 10.1016/j.jmgm.2015.09.006. Epub 2015 Sep 8.
7
Exploring the drug resistance of V32I and M46L mutant HIV-1 protease to inhibitor TMC114: flap dynamics and binding mechanism.探索V32I和M46L突变型HIV-1蛋白酶对抑制剂TMC114的耐药性:瓣片动力学和结合机制
J Mol Graph Model. 2015 Mar;56:60-73. doi: 10.1016/j.jmgm.2014.11.003. Epub 2014 Dec 5.
8
A computational analysis of binding modes and conformation changes of MDM2 induced by p53 and inhibitor bindings.基于 p53 和抑制剂结合诱导的 MDM2 结合模式和构象变化的计算分析。
J Comput Aided Mol Des. 2013 Nov;27(11):965-74. doi: 10.1007/s10822-013-9693-z. Epub 2013 Nov 22.
9
Energetic basis for drug resistance of HIV-1 protease mutants against amprenavir.HIV-1 蛋白酶突变体对安普那韦耐药的能量基础。
J Comput Aided Mol Des. 2012 Feb;26(2):215-32. doi: 10.1007/s10822-012-9550-5. Epub 2012 Feb 14.
10
Insights into scFv:drug binding using the molecular dynamics simulation and free energy calculation.利用分子动力学模拟和自由能计算深入了解 scFv:药物结合。
J Mol Model. 2011 Aug;17(8):1919-26. doi: 10.1007/s00894-010-0892-4. Epub 2010 Nov 26.
Binding free energy contributions of interfacial waters in HIV-1 protease/inhibitor complexes.
HIV-1蛋白酶/抑制剂复合物中界面水的结合自由能贡献
J Am Chem Soc. 2006 Sep 13;128(36):11830-9. doi: 10.1021/ja058042g.
4
A computational analysis of the binding affinities of FKBP12 inhibitors using the MM-PB/SA method.使用MM-PB/SA方法对FKBP12抑制剂的结合亲和力进行的计算分析。
Proteins. 2006 Sep 1;64(4):1058-68. doi: 10.1002/prot.21044.
5
Benchmarking pK(a) prediction.对pK(a)预测进行基准测试。
BMC Biochem. 2006 Jun 2;7:18. doi: 10.1186/1471-2091-7-18.
6
Some insights into the stereochemistry of inhibition of macrophage migration inhibitory factor with 2-fluoro-p-hydroxycinnamate and its analogues from molecular dynamics simulations.基于分子动力学模拟对2-氟对羟基肉桂酸及其类似物抑制巨噬细胞迁移抑制因子的立体化学的一些见解。
J Med Chem. 2005 Nov 17;48(23):7208-14. doi: 10.1021/jm050562z.
7
Validation and use of the MM-PBSA approach for drug discovery.MM-PBSA方法在药物发现中的验证与应用。
J Med Chem. 2005 Jun 16;48(12):4040-8. doi: 10.1021/jm049081q.
8
Loop conformation and dynamics of the Escherichia coli HPPK apo-enzyme and its binary complex with MgATP.大肠杆菌HPPK脱辅基酶及其与MgATP二元复合物的环构象和动力学
Biophys J. 2005 Jul;89(1):95-106. doi: 10.1529/biophysj.105.061556. Epub 2005 Apr 8.
9
Insights into saquinavir resistance in the G48V HIV-1 protease: quantum calculations and molecular dynamic simulations.对G48V HIV-1蛋白酶中沙奎那韦耐药性的见解:量子计算和分子动力学模拟
Biophys J. 2005 Feb;88(2):867-79. doi: 10.1529/biophysj.104.046110. Epub 2004 Nov 12.
10
Insights into protein-protein binding by binding free energy calculation and free energy decomposition for the Ras-Raf and Ras-RalGDS complexes.通过结合自由能计算和自由能分解对Ras-Raf和Ras-RalGDS复合物进行蛋白质-蛋白质结合的深入研究。
J Mol Biol. 2003 Jul 18;330(4):891-913. doi: 10.1016/s0022-2836(03)00610-7.